Short Description

BRAF is a member of the mitogen-activated protein/extracellular signal-regulated (MAP/ERK) kinase pathway, which plays a role in cell_x000D_ proliferation and differentiation. Dysregulation of this pathway is a key factor in tumor progression & cell proliferation. This genetic alteration has been detected in a variety of tumors like Melanoma, Colorectal cancer, Papillary thyroid carcinoma, Hairy cell leukemia, Langerhans cell histiocytosis & Pleomorphic xanthoastrocytomas. Targeted therapies directed to components of this pathway have demonstrated some success with increases both in progression-free and overall survival. Approximately 44% to 70% of Melanoma cases have a BRAF mutation, and of those, approximately 50% to 90% are the V600E mutation.

PreTest Information

Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Detail Description

IMMUNOHISTOCHEMISTRY BRAF V600E Test Cost INR:3500 Symptoms Diagnosis

Are you looking for an accurate and affordable test to diagnose BRAF V600E mutations? Look no further than DNA Labs India's Immunohistochemistry BRAF V600E Test. This test is designed to detect the presence of the BRAF V600E mutation, which is commonly found in many types of cancer.

Symptoms of BRAF V600E Mutation

The BRAF V600E mutation is associated with several types of cancer, including melanoma, colorectal cancer, and thyroid cancer. If you are experiencing any of the following symptoms, it may be a sign of a BRAF V600E mutation:

• Skin lesions
• Unexplained weight loss
• Changes in bowel habits
• Difficulty swallowing
• Lumps in the neck or throat
• Persistent cough

If you are experiencing any of these symptoms, it is important to talk to your doctor about getting tested for the BRAF V600E mutation.

Diagnosis of BRAF V600E Mutation

The Immunohistochemistry BRAF V600E Test is a simple and effective way to diagnose the BRAF V600E mutation. This test is performed on a tissue sample taken from the affected area, which is then analyzed in a laboratory to determine if the BRAF V600E mutation is present.

Once the test results are available, your doctor will be able to provide you with a diagnosis and recommend a course of treatment if necessary.

Cost of Immunohistochemistry BRAF V600E Test

The cost of the Immunohistochemistry BRAF V600E Test at DNA Labs India is INR 3500. This is an affordable price for a highly accurate test that can help diagnose the presence of the BRAF V600E mutation.

Why Choose DNA Labs India?

At DNA Labs India, we are committed to providing our customers with the highest quality testing services at an affordable price. Our team of experienced professionals uses the latest technology and techniques to ensure accurate and reliable results.

In addition to the Immunohistochemistry BRAF V600E Test, we offer a wide range of other testing services, including DNA testing, drug testing, and forensic testing. Whether you are a healthcare professional looking for a reliable testing partner or an individual looking for answers, DNA Labs India is here to help.

Conclusion

If you are experiencing symptoms of the BRAF V600E mutation or have been diagnosed with cancer, it is important to get tested for the presence of this mutation. The Immunohistochemistry BRAF V600E Test at DNA Labs India is an affordable and effective way to diagnose this mutation and get the answers you need.

BRAF is a member of the mitogen-activated protein/extracellular signal-regulated (MAP/ERK) kinase pathway, which plays a role in cell proliferation and differentiation. Dysregulation of this pathway is a key factor in tumor progression & cell proliferation. This genetic alteration has been detected in a variety of tumors like Melanoma, Colorectal cancer, Papillary thyroid carcinoma, Hairy cell leukemia, Langerhans cell histiocytosis & Pleomorphic xanthoastrocytomas. Targeted therapies directed to components of this pathway have demonstrated some success with increases both in progression-free and overall survival. Approximately 44% to 70% of Melanoma cases have a BRAF mutation, and of those, approximately 50% to 90% are the V600E mutation.